MILD COGNITIVE IMPAIRMENT (MCI) DUE TO ALZHEIMER'S DISEASE
Clinical trials for MILD COGNITIVE IMPAIRMENT (MCI) DUE TO ALZHEIMER'S DISEASE explained in plain language.
Never miss a new study
Get alerted when new MILD COGNITIVE IMPAIRMENT (MCI) DUE TO ALZHEIMER'S DISEASE trials appear
Sign up with your email to follow new studies for MILD COGNITIVE IMPAIRMENT (MCI) DUE TO ALZHEIMER'S DISEASE, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
Could an HIV drug tame brain inflammation in Alzheimer's? new study aims to find out
Disease control Recruiting nowThis study tests whether a drug called leronlimab is safe for people with Alzheimer's disease or mild cognitive impairment due to Alzheimer's. It also looks at whether the drug can reduce inflammation in the brain. Twenty volunteers aged 50 and older will receive weekly injection…
Matched conditions: MILD COGNITIVE IMPAIRMENT (MCI) DUE TO ALZHEIMER'S DISEASE
Phase: PHASE2 • Sponsor: Weill Medical College of Cornell University • Aim: Disease control
Last updated May 26, 2026 09:08 UTC
-
Could a light cap boost your memory?
Symptom relief Recruiting nowThis study tests a non-invasive light therapy device (Neuro RX Gamma) for people with mild cognitive impairment (MCI) due to Alzheimer's disease. It aims to see if the treatment is safe, feasible, and can improve memory and thinking. About 60 adults aged 50 and older with MCI wil…
Matched conditions: MILD COGNITIVE IMPAIRMENT (MCI) DUE TO ALZHEIMER'S DISEASE
Phase: NA • Sponsor: Unity Health Toronto • Aim: Symptom relief
Last updated May 20, 2026 11:56 UTC